Newsroom

Sorted by: Latest
-

HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  16-March-2026 Issue: CLYDESDALE BANK PLC Series 10 XS3095269539 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 22-December-2025 Date To: 23-March-2026 Record Date: 20-March-2026 Value Date: 23-March-2026 Benchmark Rate: 3.76279% Margin: 0.8% Total Rate: 4.56279% Floor: 0% Number of Days: 91 Day Count: Actual / 365 (Fixed) Interest Frequency: Quarterly Denomination: GBP 1,000.0...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 16.03.2026 FGBL.LN IE00BYTH6121 810,944.00 USD 74,102,492.78 91.378  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 16.03.2026 FKUD IE00BD9N0445 118,031.00 GBP 3,369,657.00 28.549  ...
-

Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL®9 and GARDASIL® at the EUROGIN International Multidisciplinary HPV Congress 2026

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced it will present new clinical and real-world data reaffirming the long-term effectiveness of the company’s 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) and its 4-valent HPV vaccine, GARDASIL® (Human Papillomavirus 4-valent Vaccine, Recombinant) against certain HPV-related cancers and diseases at the EUROGIN Interna...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 16.03.2026 FKU IE00B8X9NZ57 209,100.00 GBP 8,505,407.07 40.676  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 16.03.2026 FEUD IE00BF2FL590 359,454.00 EUR 18,688,811.56 51.992  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 16.03.2026 FEUZ IE00B8X9NY41 1,959,822.00 EUR 114,845,089.67 58.600  ...
-

Ferguson Enterprises Inc. UK Regulatory Announcement: Ferguson Enterprises Inc. (“Company”): Director/PDMR Shareholding

NEWPORT NEWS, Va.--(BUSINESS WIRE)--  NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (“PDMRs”) IN COMMON STOCK OF PAR VALUE $0.0001 EACH IN THE COMPANY (“Shares”) Awards made under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan (“Omnibus Plan”) On March 12, 2026, the Company granted Performance Awards, Restricted Stock Unit Awards and Non-Qualified Stock Option Awards under the Omnibus Plan. Details of the vesting criteria and performance condi...
-

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the randomized Phase 2 FOURLIGHT-1 study evaluating atirmociclib in combination with fulvestrant, versus fulvestrant or everolimus plus exemestane, in people with hormone receptor (HR)-positive, human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer (MBC) who had received prior cyclin-dependent kinase (CDK) 4/6 inhibitor-based treatment. The study met its prim...
-

Ferguson Enterprises Inc. (“Company”): Director/PDMR Shareholding

NEWPORT NEWS, Va.--(BUSINESS WIRE)--NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (“PDMRs”) IN COMMON STOCK OF PAR VALUE $0.0001 EACH IN THE COMPANY (“Shares”) Awards made under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan (“Omnibus Plan”) On March 12, 2026, the Company granted Performance Awards, Restricted Stock Unit Awards and Non-Qualified Stock Option Awards under the Omnibus Plan. Details of the vesting criteria and performance conditi...